Molecular DiversityPub Date : 2026-12-01Epub Date: 2026-09-19DOI: 10.1007/s11030-026-11713-0
Prerna Bansal, Kamna Srivastava
{"title":"Structure-based drug repurposing and in vitro evaluation of VAV2-associated candidates for suppression of macrophage foam-cell formation in atherosclerosis.","authors":"Prerna Bansal, Kamna Srivastava","doi":"10.1007/s11030-026-11713-0","DOIUrl":"10.1007/s11030-026-11713-0","url":null,"abstract":"<p><p>Cardiovascular disease remains a leading cause of mortality worldwide, and macrophage-derived foam-cell formation represents an important event in atherosclerosis. VAV2, a Rho-family guanine nucleotide-exchange factor, participates in signalling pathways associated with oxidized low-density lipoprotein uptake and macrophage lipid accumulation. In this study, a structure-based drug-repurposing workflow was used to identify clinically relevant compounds with predicted affinity for a full-length VAV2 structural model. Virtual screening, molecular docking, ADMET prediction, three independent 200-ns molecular-dynamics simulations, principal-component analysis, and MM-PBSA calculations prioritized talazoparib, tivozanib, and isradipine for further evaluation. In THP-1-derived macrophages, talazoparib reduced oxLDL-induced intracellular neutral-lipid accumulation at a sub-cytotoxic concentration. In a complementary DiI-oxLDL assay, all three compounds reduced cell-associated DiI-oxLDL fluorescence relative to vehicle control. These findings provide preliminary computational and cellular support for further investigation of the selected compounds. However, direct binding to or inhibition of VAV2 has not been demonstrated and requires biochemical, genetic, pharmacological, and in vivo validation.</p>","PeriodicalId":708,"journal":{"name":"Molecular Diversity","volume":" ","pages":"11153-11176"},"PeriodicalIF":4.3,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149007862","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Molecular DiversityPub Date : 2026-12-01Epub Date: 2026-06-28DOI: 10.1007/s11030-026-11640-0
Antonio Viayna, Javier E Ortiz, Frederick Schosinsky, William J Zamora, Gabriela Egly Feresin
{"title":"Candimine as a natural scaffold for targeting squalene synthetase in Trypanosoma cruzi: insights from computational studies.","authors":"Antonio Viayna, Javier E Ortiz, Frederick Schosinsky, William J Zamora, Gabriela Egly Feresin","doi":"10.1007/s11030-026-11640-0","DOIUrl":"10.1007/s11030-026-11640-0","url":null,"abstract":"<p><p>Chagas disease (CD), caused by the kinetoplastid protozoan Trypanosoma cruzi, remains a major neglected tropical illness with limited therapeutic options. Natural products have historically provided structurally diverse scaffolds that serve as privileged templates in medicinal chemistry. Candimine (Cnd), an alkaloid isolated from Hippeastrum escoipense (Amaryllidaceae), has recently emerged as a promising compound with activity against T. cruzi. Although its antiparasitic effects are well documented, the precise molecular targets of Cnd have not been fully defined. The aim of this study was to perform a structure‑based molecular modeling analysis to investigate the direct interaction between candimine and key proteins essential for the survival of T. cruzi. The molecular docking and dynamics simulations revealed favorable interactions between Cnd and T. cruzi squalene synthetase (TcSQS), consistent with previously reported in vitro findings. Docking and simulation analyses showed that Cnd interacts favorably with this target, supporting a mechanism consistent with previous in vitro trypanocide activities. This is the first report to explore potential molecular mechanisms of action, offering new insights into TcSQS as a plausible target and positioning Cnd as a promising natural scaffold for developing next-generation therapies for CD.</p>","PeriodicalId":708,"journal":{"name":"Molecular Diversity","volume":" ","pages":"9767-9784"},"PeriodicalIF":4.3,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148337393","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Molecular DiversityPub Date : 2026-12-01Epub Date: 2026-06-30DOI: 10.1007/s11030-026-11641-z
Saida Lachhab, Soukaina Elmoussaoui, Meriem Rafya, Az-Eddine El Mansouri, Ahmad Mehdi, Raquel R Ramalhosa, Ana R Costa, Elisabete P Carreiro, Graciela Andrei, Robert Snoeck, Fatiha Benkhalti, Yogesh S Sanghvi, Mustapha Ait Ali, Hassan B Lazrek
{"title":"Discovery of novel perillyl and myrtenyl nucleobase conjugates as dual anti-Alzheimer and antimicrobial agents.","authors":"Saida Lachhab, Soukaina Elmoussaoui, Meriem Rafya, Az-Eddine El Mansouri, Ahmad Mehdi, Raquel R Ramalhosa, Ana R Costa, Elisabete P Carreiro, Graciela Andrei, Robert Snoeck, Fatiha Benkhalti, Yogesh S Sanghvi, Mustapha Ait Ali, Hassan B Lazrek","doi":"10.1007/s11030-026-11641-z","DOIUrl":"10.1007/s11030-026-11641-z","url":null,"abstract":"<p><p>Recent studies suggest that Alzheimer's disease may be influenced by microbial infections and may involve multiple microbial pathogens contributing to its development and progression. Based on this hypothesis, dual antimicrobial and anti-Alzheimer's agents may provide advantages such as improved therapeutic effectiveness, treatment of infection-related Alzheimer disease, and reduced toxicity compared with single-target drugs. To discover novel therapeutic agents, a series of terpene-substituted pyrimidine derivatives were synthesized and evaluated for their antiviral, antibacterial, antifungal and anti-Alzheimer's activities. All compounds were characterized by spectroscopic methods to support their structures. Among all compounds screened for their biological activity, compounds 11 and 32 displayed excellent IC50 values of 10.1 and 9.9 µM, respectively, against eqBChE in comparison with Food and Drug Administration (FDA)-approved drugs galantamine (IC<sub>50</sub> = 20.6 µM) and donepezil (IC<sub>50</sub> = 4.1 µM) for the treatment of Alzheimer's disease (AD). Additionally, compound 32 exhibited promising antifungal activity against C. tropicalis (MIC = 0.83 µmol/ml and MFC = 1.69 µmol/ml), showing two-fold greater potency than fluconazole and three-fold greater potency than 5-fluorocytosine. Moreover, terpene derivative 32 showed moderate antibacterial activity against Pseudomonas aeruginosa, Staphylococcus aureus, Escherichia coli, and Enterococcus faecalis, with MIC and MBC values ranging from 3.35 to 6.71 µmol/ml. The docking studies of 32 with eqBChE supported the observed in vitro results. This study provides a promising lead compound with dual antimicrobial and anti-Alzheimer activity that may be further developed as a potential therapeutic agent for the treatment of Alzheimer's disease.</p>","PeriodicalId":708,"journal":{"name":"Molecular Diversity","volume":" ","pages":"9875-9891"},"PeriodicalIF":4.3,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148350252","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Prediction and mechanistic insights into drug-induced reproductive toxicity through integrated machine learning, FAERS-based signal comparison, and network toxicology analyses.","authors":"Jiawang Yan, Yaofeng Zhou, Yihuan Zhao, Fushan Tang","doi":"10.1007/s11030-026-11654-8","DOIUrl":"10.1007/s11030-026-11654-8","url":null,"abstract":"<p><p>Drug-induced reproductive toxicity is a critical concern in drug safety evaluation, whereas conventional assessment methods are often constrained by high costs and long experimental cycles. In this study, a machine learning-based predictive model for reproductive toxicity was developed and integrated with data from the FDA Adverse Event Reporting System (FAERS), network toxicology analysis, molecular docking, and molecular dynamics simulation to systematically evaluate the post-marketing reproductive toxicity risk of drugs and explore their potential mechanisms. Among the evaluated machine learning algorithms, LightGBM demonstrated the best overall performance, achieving an F1-score of 0.854, a ROC-AUC of 0.933, a PR-AUC of 0.931, and an MCC of 0.705 on the independent test set, with robust generalization confirmed by ten-fold cross-validation. Among drugs approved between 2015 and 2024, 72 were predicted to have a high risk of reproductive toxicity. FAERS-based signal comparison showed that 55 of these drugs (76.39%) were associated with reproductive toxicity-related adverse event reports, indicating consistency between model predictions and FAERS-reported reproductive toxicity-related adverse events. Network toxicology analysis identified 12 key targets, including ESR1, IGF1, and AKT1, that may be involved in reproductive toxicity. Molecular docking showed that drugs with high predicted reproductive toxicity risk could bind effectively to multiple toxicity-related targets, while molecular dynamics simulations confirmed stable interactions between selected drugs and ESR1, mainly through hydrogen-bonding and hydrophobic interactions. Favorable binding free energies further supported their potential multi-target effects. Overall, this integrated strategy combining predictive modeling with FAERS-based signal comparison provides a useful framework for drug safety evaluation and mechanistic investigation of reproductive toxicity.</p>","PeriodicalId":708,"journal":{"name":"Molecular Diversity","volume":" ","pages":"10133-10157"},"PeriodicalIF":4.3,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148417650","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Molecular DiversityPub Date : 2026-12-01Epub Date: 2026-07-06DOI: 10.1007/s11030-026-11653-9
Trung Hai Nguyen, Hang N T Nguyen, Minh Quan Pham, Huong Thi Thu Phung
{"title":"Tetrapeptide inhibitors of BACE-1 revealed by combined data-driven screening and physics-based free-energy refinement.","authors":"Trung Hai Nguyen, Hang N T Nguyen, Minh Quan Pham, Huong Thi Thu Phung","doi":"10.1007/s11030-026-11653-9","DOIUrl":"10.1007/s11030-026-11653-9","url":null,"abstract":"<p><p>Alzheimer's disease remains a major global health challenge, and β-site amyloid precursor protein cleaving enzyme 1 (BACE-1) represents a critical therapeutic target as it catalyzes the rate-limiting step in amyloid-β production. While computational studies have extensively explored small-molecule BACE-1 inhibitors, large-scale screening combined with physics-based refinement has rarely been applied to peptide scaffolds. Here, we report an integrated machine learning (ML)-to- free energy perturbation (FEP) pipeline, combining XGBoost-based screening, molecular docking, replicate explicit-solvent molecular dynamics (MD), and absolute FEP calculations, as a multi-stage alternative to single-scoring approaches for tetrapeptide lead discovery against BACE-1. Screening a library of 16,000 tetrapeptides with an XGBoost model prioritized four candidates (HWRE, HWER, WHRR, and HWRQ) for structure-based evaluation. Molecular docking confirmed favorable positioning within the catalytic cleft, while replicate MD simulations revealed multivalent binding through hydrogen bonds, salt bridges to the catalytic dyad (Asp32/Asp228), and hydrophobic contacts with conserved pocket residues; interaction-fingerprint and hotspot analyses provided residue-level guidance for optimization. FEP calculations delivered quantitative thermodynamic ranking, separating three strong predicted binders (HWRE, WHRR, HWRQ; ΔG<sub>FEP</sub> = - 29.45 to - 32.00 kcal mol<sup>-1</sup>) from the weaker candidate HWER (ΔG<sub>FEP</sub> = - 14.78 kcal mol<sup>-1</sup>). The three high-affinity peptides share a conserved H/W/R motif with persistent dyad anchoring and dense hydrogen-bond networks, a compact scaffold amenable to peptidomimetic optimization, with HWRE as the top lead across all computational stages. This study delivers experimentally testable tetrapeptide candidate inhibitors and establishes a scalable framework for peptide-based ligand discovery against BACE-1 and related aspartyl proteases.</p>","PeriodicalId":708,"journal":{"name":"Molecular Diversity","volume":" ","pages":"9961-9974"},"PeriodicalIF":4.3,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148389772","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Molecular DiversityPub Date : 2026-12-01Epub Date: 2026-09-03DOI: 10.1007/s11030-026-11726-9
Md Ataul Islam, Mohammad Ajmal Ali, Rupesh Chikhale, Md Lutful Islam, Mohammad Abul Farah
{"title":"Free energy perturbation and machine learning-assisted identification of novel molecules for the Mycobacterium tuberculosis KasA protein: a fragment-based drug design approach.","authors":"Md Ataul Islam, Mohammad Ajmal Ali, Rupesh Chikhale, Md Lutful Islam, Mohammad Abul Farah","doi":"10.1007/s11030-026-11726-9","DOIUrl":"10.1007/s11030-026-11726-9","url":null,"abstract":"<p><p>KasA is an essential enzyme of Mycobacterium tuberculosis (Mtb). It plays a critical role in synthesizing long-chain mycolic acids, the major components of the bacterial cell wall, by regulating the FAS-I and FAS-II fatty acid synthesis pathways. Inhibiting KasA offers a promising strategy for treating tuberculosis (TB). This study used fragment-based drug design (FBDD) to design novel small molecules targeting KasA. Fragments from known KasA inhibitors were generated with the MacFrag tool and then combined with Fragmenstein to create potential hit compounds. A multi-tiered molecular docking approach was used to evaluate their binding affinity and interactions with KasA. Selected candidates underwent pharmacokinetic analysis and molecular dynamics (MD) simulations. Five promising molecules, namely KasA_FB1, KasA_FB2, KasA_FB3, KasA_FB4 and KasA_FB5, were identified. Their molecular docking binding energies were - 7.80, - 8.30, - 9.00, - 7.80, and - 9.00 kcal/mol, respectively, all superior to the reference co-crystal ligand TLM (- 7.20 kcal/mol). MD simulations showed that their dynamic stability was comparable to or better than TLM. MM-GBSA and free energy perturbation (FEP) analyses further confirmed their superior binding affinity for KasA. These compounds represent promising candidates for the development of new anti-TB drugs targeting KasA and warrant experimental validation.</p>","PeriodicalId":708,"journal":{"name":"Molecular Diversity","volume":" ","pages":"10961-10992"},"PeriodicalIF":4.3,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148885769","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Artificial intelligence-guided discovery of fungal ergosterol derivatives as selective LXRβ agonists targeting the cholesterol dependency of glioblastoma.","authors":"Qi Li, Chunxue Zhang, Tiantian Hu, Zhenzhen Zhang, Haigang Wu","doi":"10.1007/s11030-026-11728-7","DOIUrl":"10.1007/s11030-026-11728-7","url":null,"abstract":"<p><p>Glioblastoma (GBM) is the most lethal primary brain malignancy, for which no new systemic therapy has achieved regulatory approval in over past decade. A molecular vulnerability of GBM is its comprehensive co-dependency on exogenous cholesterol to sustain oncogenic signaling and membrane biogenesis, rendering the liver X receptor beta (LXRβ)-the principal transcriptional regulator of cholesterol efflux in the central nervous system-an attractive therapeutic target. However, the development of LXRβ-selective, blood-brain barrier (BBB)-penetrant agonists that avoid the hepatotoxicity associated with LXRα co-activation has remained an unresolved challenge. Here, we developed an integrated artificial intelligence-based virtual screening pipeline. The pipeline integrates ML-QSAR modelling, D-MPNN, and deep learning-based DTI prediction. It was applied to systematically interrogate a curated library of ~ 1.2 million natural products. Sequential filtering by predicted LXRβ affinity, LXRβ/LXRα selectivity, and integrated pharmacokinetic scoring, refined by molecular docking and MM-GBSA binding free energy calculations, identified four high-confidence candidates. Experimental validation by CCK-8 cytotoxicity assays across five GBM cell lines and six normal cell models revealed that 5,6-Epoxyergosterol is a potent anti-glioma agent. Furthermore, a 200 ns molecular dynamics simulation of the LXRβ-5,6-Epoxyergosterol complex demonstrated stable binding, with dominant hydrogen-bonding contacts at His435 and Trp443 and a free energy landscape consistent with a single dominant agonist-bound conformation. These findings establish fungal ergosterol derivatives as a novel class of LXRβ-targeted therapeutics and provide a validated AI-driven framework for accelerating natural product drug discovery in neuro-oncology.</p>","PeriodicalId":708,"journal":{"name":"Molecular Diversity","volume":" ","pages":"11115-11134"},"PeriodicalIF":4.3,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148954613","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Molecular DiversityPub Date : 2026-12-01Epub Date: 2026-09-25DOI: 10.1007/s11030-026-11730-z
Nashwa H Zaher, Reham M M El-Hazek, Mohamed I Mostafa
{"title":"Evaluation of toll-like receptor inhibition by novel thymoquinone analogues as potential remedy for diabetic nephropathy.","authors":"Nashwa H Zaher, Reham M M El-Hazek, Mohamed I Mostafa","doi":"10.1007/s11030-026-11730-z","DOIUrl":"10.1007/s11030-026-11730-z","url":null,"abstract":"<p><p>Diabetic nephropathy (DN) is a major worldwide cause of chronic kidney disease and end-stage renal failure, impacting approximately 20-50% of individuals with diabetes. DN frequently progresses to end-stage renal disease. The prevalence of DN continues to increase significantly, accompanied by rising rates of death and cardiovascular complications. To date, there is no specific drug approved exclusively for the treatment of diabetic nephropathy. In this work 13 novel disubstituted TQ analogues were synthesized, recrystallized and structurally verified via microanalytical and spectral data. Screening against TLR-4 activity was performed, the most potent disubstituted propyl ether TQ13 was subjected to more in-vivo biological investigations in STZ induced hyperglycemia rats. TQ13 showed anti-hyperglycemic, antioxidant, anti-inflammatory and antiapoptotic effects in addition to amelioration of kidney function markers, TLR-2 & TLR-4 activities. The findings of this investigational study suggest that disubstituted propyl ether TQ13 may represent a promising radio-stable renoprotective candidate in DN therapeutics which needs more tentative studies on toxicity and exact mechanism of action involving advanced staging pathways.</p>","PeriodicalId":708,"journal":{"name":"Molecular Diversity","volume":" ","pages":"11243-11264"},"PeriodicalIF":4.3,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149056846","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Development of a double-pharmacophore workflow for screening subtype-selective M<sub>3</sub> muscarinic acetylcholine receptor antagonists.","authors":"Sirat Kaur Gill, Sandhya Chahal, Shyam Sundar Sarkar, Tara Yadava, Jayant Sindhu, Badri N Acharya","doi":"10.1007/s11030-026-11619-x","DOIUrl":"10.1007/s11030-026-11619-x","url":null,"abstract":"<p><p>M<sub>3</sub> subtype of muscarinic acetylcholine receptors (mAChRs) is a very important drug target validated for irritable bowel syndrome (IBS), over active bladder (OAB), and chronic obstructive pulmonary disease (COPD). The M<sub>2</sub> subtype has high sequence and structural similarity with M<sub>3</sub>. This makes it difficult to design selective inhibitors for M<sub>3</sub> subtype. To address this problem, a three-dimensional quantitative structure-activity relationship (3D-QSAR) pharmacophore model was generated to estimate M<sub>2</sub> specific inhibitory constant (K<sub>i</sub>). The predictions were compared with a reported 3D-QSAR M<sub>3</sub> pharmacophore model to calculate M<sub>3</sub>/M<sub>2</sub> selectivity ratio. This double-pharmacophore workflow was validated over known M<sub>3</sub> antagonists. It was then applied to virtually screen a focused PubChem library with 'piperazine-triazole' scaffold. The top-ranked M<sub>3</sub> selective candidates (10673583 and 46934496) were further studied for their molecular interactions at the orthosteric binding pocket of both M<sub>2</sub> and M<sub>3</sub> in silico, such as Molecular Mechanics/Poisson-Boltzmann Surface Area (MM/PBSA) and, Molecular Mechanics/Generalized Born Surface Area (MM/GBSA). The results predicted strong hydrogen bonding along with hydrophobic, hydrophilic, and π-π interactions of the M<sub>3</sub> receptor-ligand complexes over M<sub>2</sub>.</p>","PeriodicalId":708,"journal":{"name":"Molecular Diversity","volume":" ","pages":"9723-9744"},"PeriodicalIF":4.3,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148337423","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Molecular DiversityPub Date : 2026-12-01Epub Date: 2026-07-09DOI: 10.1007/s11030-026-11648-6
Kailai Zhou, Jinming Guo, Yang Cao, Ziqi Xu, Yanbu Guo
{"title":"Heterogeneous dual-channel and interpretable graph representation learning with global virtual nodes for microRNA-mediated drug sensitivity prediction.","authors":"Kailai Zhou, Jinming Guo, Yang Cao, Ziqi Xu, Yanbu Guo","doi":"10.1007/s11030-026-11648-6","DOIUrl":"10.1007/s11030-026-11648-6","url":null,"abstract":"<p><p>Drug sensitivity critically affects therapeutic outcomes, and microRNAs (miRNAs) play a key role in regulating drug response by modulating genes involved in drug metabolism and action. However, existing computational methods for predicting miRNA-drug sensitivity associations are often limited by heterogeneous network structures and severe data sparsity, which hinder effective feature propagation and robust learning. To address these challenges, we propose HDIGRL, a channel-aware heterogeneous graph representation learning framework centered on channel-gated global heterogeneous propagation for miRNA-mediated drug sensitivity prediction. HDIGRL models miRNAs and drugs from complementary structural and interaction-derived perspectives via a dual-channel feature extraction strategy. HDIGRL introduces channel-gated global heterogeneous propagation, in which global virtual nodes first enable graph-level context exchange and a channel-wise propagation gate then recalibrates propagated embeddings to emphasize discriminative feature channels and suppress noisy or redundant ones. In addition, an imbalance-aware focal loss is adopted to improve robustness under extreme class imbalance. Experimental results on public datasets demonstrate that HDIGRL consistently outperforms existing methods, and further analyses reveal latent miRNA-mediated drug-sensitivity pathways, highlighting its potential for predictive modeling and biological interpretation.</p>","PeriodicalId":708,"journal":{"name":"Molecular Diversity","volume":" ","pages":"9997-10017"},"PeriodicalIF":4.3,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148410115","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}